Rolf Werner
Board Member
Kemwell
Sweden
Biography
Rolf G. Werner is one of the worldwide leading experts in the area of research, development and production of safe and efficient antibiotics, biopharmaceuticals and vaccines with more than three years in academia at Max Planck Institute for Molecular Genetics, Berlin, Germany and Massachusetts Institute of Technology, Cambridge, USA and more than 35 years experience in industry at Boehringer Ingelheim in leading positions. He identified new antibiotics and optimized lead compounds to improve patient benefit. He was responsible for the development and registration of the first, genetically engineered, protein therapeutic from mammalian cell culture: tissue plasminogen activator for myocardial infarctio and stroke. More than 20 therapeutic proteins and monoclonal antibodies have been developed, manufactured and regulatory approved under his responsibility. Under his supervision, processes for vaccines have been developed.
Research Interest
His area of research includes the following- Development and production of safe and efficient antibiotics, bio-pharmaceuticals and vaccines.
